A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor.
Plummer R, Rees C, Hughes A, Beale P, Highley M, Trigo J, Gokul S, Judson I, Calvert H, Jackman A, Mitchell F, Smith R, Douglass E.
Plummer R, et al. Among authors: douglass e.
Clin Cancer Res. 2003 Apr;9(4):1313-22.
Clin Cancer Res. 2003.
PMID: 12684399
Clinical Trial.